Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison
暂无分享,去创建一个
É. Chaim | E. Cazzo | M. A. Gestic | F. Callejas-Neto | M. P. Utrini | F. M. Chaim | C. Germano | G. H. Callejas | F. Maldonado | Paulo Ferreira Mega | Luana Leite Castilho Dias
[1] É. Chaim,et al. Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study , 2022, Sao Paulo medical journal = Revista paulista de medicina.
[2] E. Cazzo,et al. Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study , 2022, Obesity Surgery.
[3] É. Chaim,et al. SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS. , 2022, Arquivos de gastroenterologia.
[4] H. Healy,et al. The use of very low‐calorie diets in subjects with obesity complicated with nonalcoholic fatty liver disease: A scoping review , 2022, Obesity science & practice.
[5] Dorothy D. Sears,et al. WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Insulin and Insulin Resistance in Breast Cancer Survivors , 2021, Nutrients.
[6] V. Kristiansen,et al. Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies , 2021, Journal of clinical medicine.
[7] F. Sacks,et al. Temporal and mediation relations of weight loss, and changes in insulin resistance and blood pressure in response to 2-year weight-loss diet interventions: the POUNDS Lost trial , 2021, European Journal of Nutrition.
[8] M. Imamura,et al. Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients , 2021, Medicine.
[9] B. Neuschwander‐Tetri,et al. NAFLD: Reporting Histologic Findings in Clinical Practice , 2021, Hepatology.
[10] É. Chaim,et al. Non-Invasive Markers in Non-Alcoholic Fatty Liver Disease: Reliability Is Variable According to BMI Status , 2021, Obesity Surgery.
[11] B. Neuschwander‐Tetri,et al. Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice. , 2020, Hepatology.
[12] A. Kırık,et al. Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease? , 2020, Acta gastro-enterologica Belgica.
[13] H. Garg,et al. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan , 2020, Obesity Surgery.
[14] K. Hachey,et al. Gender disparities in weight loss surgery , 2020 .
[15] A. Sultan,et al. Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels , 2020, Journal of gastroenterology and hepatology.
[16] É. Chaim,et al. Influence of post-Roux-en-Y gastric bypass weight recidivism on insulin resistance: a 3-year follow-up. , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[17] A. Suzuki,et al. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps , 2019, Hepatology.
[18] E. Muradova,et al. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[19] Michael Charlton,et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.
[20] J. Pareja,et al. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review , 2017, Sao Paulo medical journal = Revista paulista de medicina.
[21] Robert V Farese,et al. Lipid droplets and liver disease: from basic biology to clinical implications , 2017, Nature Reviews Gastroenterology &Hepatology.
[22] J. Pareja,et al. Influence of Insulin Resistance Status on the Development of Gallstones Following Roux-En-Y Gastric Bypass: a Prospective Cohort Study , 2016, Obesity Surgery.
[23] P. Senthilnathan,et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[24] S. Friedman,et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. , 2015, Gastroenterology.
[25] J. Lippincott-Schwartz,et al. Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. , 2015, Developmental cell.
[26] B. Ammori,et al. Weight loss and metabolic outcomes of bariatric surgery in men versus women - A matched comparative observational cohort study. , 2014, European journal of internal medicine.
[27] J. Pareja,et al. Nonalcoholic Fatty Liver Disease in Morbidly Obese Subjects: Correlation Among Histopathologic Findings, Biochemical Features, and Ultrasound Evaluation , 2014, Obesity Surgery.
[28] N. Chalasani,et al. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD) , 2013, Hepatology International.
[29] N. Bhala,et al. Epidemiology and natural history of patients with NAFLD. , 2013, Current pharmaceutical design.
[30] Raj Vuppalanchi,et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. , 2011, Journal of hepatology.
[31] Gustavo E. Guajardo-Salinas,et al. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Utility of FIBROspect II to Detect Liver Fibrosis in Morbidly Obese Hispano-American Patients Undergoing Gastric Bypass , 2010, Obesity surgery.
[32] E. Jackvony,et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.
[33] P. Schauer,et al. Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort , 2009, Obesity.
[34] B. Neuschwander‐Tetri,et al. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network , 2009, Hepatology.
[35] S. Jang,et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[36] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[37] I. Leitman,et al. Gender as a Deterministic Factor in Procedure Selection and Outcomes in Bariatric Surgery , 2021, JSLS : Journal of the Society of Laparoendoscopic Surgeons.
[38] J. Pareja,et al. Preoperative multidisciplinary program for bariatric surgery: a proposal for the Brazilian Public Health System. , 2017, Arquivos de gastroenterologia.